COMET Initiative | Critically Important Cancer Outcomes to Report in Kidney Transplant Trials

Critically Important Cancer Outcomes to Report in Kidney Transplant Trials

No abstract available

Contributors

Ellen Dobrijevic, Anita van Zwieten, Allison Jaure, Amy von Huben, Martin Howell, Armando Teixeira-Pinto, Sergio A Acuna, Curie Ahn, Christopher D Blosser, Jonathan C Craig, Bianca Davidson, Anna Francis, Kenar D Jhaveri, Jolanta Malyszko, Kenneth A Newell, Alejandra Mena-Gutierrez, Naoka Murakami, Nicole Scholes-Robertson, Helio Tedesco Silva, Germaine Wong

Publication

Journal: Kidney International Reports
Volume: 10
Issue: 10
Pages: 3664 - 3669
Year: 2025
DOI: https://doi.org/10.1016/j.ekir.2025.07.006

Further Study Information

Current Stage: Completed
Date:
Funding source(s): AJ and GW are recipients of the National Health and Medical Research Council Investigator Award (APP1197324 and AP1195414, respectively). The funding organization had no role in the design and approval of the article.

Health Area

Disease Category: Kidney disease

Disease Name: Cancer, Kidney Transplant

Target Population

Age Range: 18 - 100

Sex: Either

Nature of Intervention: Any

Stakeholders Involved

- Clinical experts
- Consumers (caregivers)
- Consumers (patients)

Study Type

- Patient perspectives
- Recommendations made

Method(s)

- Survey